Selective molecular potassium channel blockade prevents atrial fibrillation

摘要

BackgroundSafety and efficacy limit currently available atrial fibrillation (AF) therapies. We hypothesized that atrial gene transfer would allow focal manipulation of atrial electrophysiology, and by eliminating reentry, would prevent AF.